Clinical Trial Information Request for Protocol 2024P000117 Title A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Determine the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, for Stroke Prevention after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack-LIBREXIA-STROKE (Sponsor protocol 70033093STR3001) PI Site Directions: Type your name, contact email and phone number (optional) into the boxes below then click Save to Submit your request for information about this study. Name Email Phone